Supreme Court Term 2025-2026

The Minnesota Supreme Court is poised to decide whether there are any circumstances in which someone subjected to an unconstitutional traffic stop can suppress evidence that he temporarily avoided the police when they initiated the unconstitutional stop. The Minnesota Court of Appeals held that evidence of even temporary “flight” can never be suppressed—even when someone simply delays acquiescing to an unconstitutional traffic stop—on the theory that fleeing from the police is a crime. The ACLU’s State Supreme Court Initiative, along with the ACLU of Minnesota and the law firm Faegre Drinker Biddle & Reath LLP, filed an amicus brief arguing that Article I, Sections 8 and 10 of the Minnesota Constitution—which guarantee Minnesotans remedies for constitutional violations and protect them from unreasonable searches and seizures—require a broad application of the exclusionary rule. Accordingly, we argue that the Court should use a flexible, multi-factor test that can allow for suppression of evidence where a suspect, as in this case, responds to an illegal stop or seizure with nonviolent attempts to keep himself safe.

This case presents the question whether Oregonians retain a state constitutional privacy interest in their medical records, even when those records are held by health care providers. It could have important implications for patients who obtain abortions, gender-affirming care, and other health care that might be targeted by local or out-of-state law enforcement.

On May 16, 2025, the ACLU, NYCLU, and Executives Transforming Probation and Parole (EXiT) filed an amicus brief in the Second Circuit Court of Appeals, arguing that the federal government cannot impose blanket, burdensome supervised release rules during sentencing without telling the defendant.

A 2023 Idaho law criminalizing gender-affirming medical care for transgender youth is being challenged in federal court by two transgender adolescents and their families. HB 71, signed into law by Idaho Governor Brad Little in May 2023, prohibits gender-affirming medical care that is widely accepted to treat gender dysphoria, helping alleviate the distress of gender dysphoria and significantly improving patients’ mental health and well-being. Such treatment is supported by leading medical experts and all major U.S. medical organizations, including the American Medical Association, the American Psychiatric Association, and the American Academy of Pediatrics.